跳至主要内容
临床试验/CTRI/2026/03/106396
CTRI/2026/03/106396尚未招募2/3 期

Randomized Controlled Clinical Trial to Evaluate the Efficacy of Darvyadi Varti Compared with a Combination of Clindamycin Pessary and Clotrimazole in the Management of Yonigata Shwetastrava Leucorrhoea

TILAK AYURVED MAHAVIDYALAYA1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年4月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
40
试验地点
1

研究概览

简要总结

The study will be intervened by the treatment of dravaydi varti  and combination of clotrimazole and clindamycin pessary to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective and objective criteria for statistical analysis. Scoring will be designed according to the severity of symptoms. The subjective and objective gradation of symptoms will be done as follows and the intensity of each symptom will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regards to clinical signs and symptoms on the basis of grading and scoring system. The signs and symptoms will be assessed by adopting the suitable scoring method.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Age between 20- 45 years married female participants complaining of vaginal discharge.
  • Participants having cervical erosion.
  • Participants complaining of per vaginal white discharge with itching at vaginal area and staining of undergarments.

排除标准

  • Pregnant women known case of sexually transmitted diseases Known case of anaemia Known case of diabetes mellitus known case of Serology positive participantsfor HIV, HbSAg, VDRL known case of Participants with cervical/ vaginal/ endometrial malignancy known case of Participants with cervical polyp.

研究者

申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

dr Shubham Ramchandra Omase

Tilak Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验